logo

For the Inventor, By the Inventor

Rehovot, Israel

Tikva Vogel

USPTO Granted Patents = 15


Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 144(Granted Patents)


Company Filing History:

goldMedal14 out of 67 
 
Bio-technology General Corporation
 patents
silverMedal1 out of 13 
 
Savient Pharmaceuticals, Inc.
 patents

Years Active: 1989-2006

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 7087722 - Fibrin binding domain polypeptides and uses and methods of producing same (2006-08-08),
2. 6121426 - Fibrin binding domain polypeptides and uses and methods of producing same (2000-09-19),
3. 6054291 - Expression vectors for enhanced production of polypeptides, plasmids (2000-04-25),
4. 5965383 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-10-12),
5. 5869616 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-02-09),
6. 5759816 - Expression vectors containing .lambda.P.sub.L promoter and T.sub.1 (1998-06-02),
7. 5679320 - Fibrin binding domain polypeptides and uses and methods of producing same (1997-10-21),
8. 5637495 - Plasmids for production of human growth hormone or polypeptide analog (1997-06-10),
9. 5455158 - Fibrin binding domain polypeptides and uses and methods of producing same (1995-10-03),
10. 5270030 - Fibrin binding domain polypeptide and method of producing (1993-12-14),
11. 5256546 - Bacterial expression of porcine growth hormone (1993-10-26),
12. 5198361 - Plasmids for production of met-asp-gln bovine growth hormone, hosts (1993-03-30),
13. 4997916 - Method for recovering a purified animal growth hormone or polypeptide (1991-03-05),
14. 4871835 - Analogs of hGH having antagonistic activity, and uses thereof (1989-10-03),
15. 4831120 - Method for recovering a purified animal growth hormone or polypeptide (1989-05-16),

Title: Innovations of Tikva Vogel

Introduction

Tikva Vogel is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of imaging agents and polypeptides. With a total of 15 patents to his name, Vogel's work has the potential to impact medical imaging and treatment methodologies.

Latest Patents

One of Tikva Vogel's latest patents is focused on fibrin binding domain polypeptides and their uses. This invention provides an imaging agent that comprises a polypeptide labeled with an imageable marker. The polypeptide has an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and is capable of binding to fibrin. The invention further outlines a method for using the imaging agent to visualize fibrin-containing substances, such as thrombus or atherosclerotic plaque. Additionally, the patent includes plasmids for the expression of these polypeptides, methods of treatment using them, and techniques for recovering, refolding, and reoxidizing the polypeptides. The invention also ensures the availability of purified polypeptides that are substantially free of other human-origin substances.

Career Highlights

Throughout his career, Tikva Vogel has worked with notable companies in the biotechnology sector, including Bio-Technology General Corporation and Savient Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Tikva Vogel has collaborated with several professionals in his field, including Avigdor Levanon and Marian Gorecki. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Tikva Vogel's contributions to biotechnology, particularly through his patents on fibrin binding domain polypeptides, showcase his innovative spirit and dedication to advancing medical imaging technologies. His work continues to pave the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…